‘Buy American’ Drug Decision Opens Door to Foreign Supplies

A wide range of federal contractors stand to benefit from a new Federal Circuit ruling on the origins of a hepatitis drug, which could allow them to rely more on foreign-made parts or components while still satisfying “Buy American” restrictions.

“A number of companies with overseas supply chains could benefit from the decision, as long as the regulation remains unchanged, including companies that use IT components, medical device companies, and those that manufacture tools and equipment,” said Alan W.H. Gourley of Crowell & Moring LLP in Washington.

Federal agencies may only purchase articles produced in the U.S. under ...